Table: begin end state 1 26 cytoplasmic 27 47 transmembrane 48 58 non-cytoplasmic 59 76 transmembrane 77 91 cytoplasmic 92 114 transmembrane 115 123 non-cytoplasmic 124 143 transmembrane 144 149 cytoplasmic 150 168 transmembrane 169 194 non-cytoplasmic 195 217 transmembrane 218 222 cytoplasmic 223 239 transmembrane 240 240 cytoplasmic 241 244 non-cytoplasmic 245 272 transmembrane 273 293 cytoplasmic 294 297 non-cytoplasmic 298 311 transmembrane 312 317 non-cytoplasmic 318 342 transmembrane 343 366 cytoplasmic 367 405 transmembrane 406 424 cytoplasmic 425 448 transmembrane 449 451 non-cytoplasmic 452 471 transmembrane 472 479 non-cytoplasmic 480 501 transmembrane 502 506 cytoplasmic 507 537 transmembrane 538 540 non-cytoplasmic 541 558 transmembrane 559 570 cytoplasmic 571 594 transmembrane 595 599 non-cytoplasmic 600 622 transmembrane 623 630 cytoplasmic 631 660 transmembrane 661 673 non-cytoplasmic
Input: >AZOBR_RS16500 FitnessBrowser__azobra:AZOBR_RS16500 MELDEAKARELEEKFDSEIRFRPLSPLAGKLVGGLLIILSLFHYYTAGFGLLPEMEHRGI HLSFVLGLVFLVFPFTKRGYGEPVMGTLLRPLGIGLQDWALAIGAVVAVMHVPLIPLDDL AFRVGNPTTTDVILGSILIIVLLEATRRSVGWPLPIISLIFMSYAIWGPQMPGLLKHPGA TVSQLVDHLYLTTQGVYGIALGVVATYVFHFVLFGVFATRIGLGQLFLDCAAWVAGRYAG GPAKVAIFGSALFGMISGSSVANTVTVGSLTIPAMKRMGYKPHFAAAVESTASTGGQITP PIMGAAAFLMIEFLGLPYTTIIMAAIVPAFMHFFGVLVQVHFEAKRNGLRGLRPDEMPDL KEAFRRDWPTVIPLVVLIGILIAGYTPYMAAFWGITLCIAVGLLNPRKRMTIWEVLDGLR DGAKYALAVGAAAATVGIIVGVVTLTGVGFKISYIVTSTAGEMAVWAGAFLPGWLADAKA LTLLFTLIMTGVVCILMGCGIPTTANYIIMATIAAPALGLLGVAPIVAHFFVFYYGVLAD ITPPVALAAYAAAGMAGADPFKTGNTAFRLGLAKALVPFVFVFSPSLLLVAPGFNWPDFF IAFLGCIVGIVCLGATLTGWLLTNMRGWERLLLGIAAILLVTPELYSSLLGLALIVPVLL RQMSARRLMPEAA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server